SustainabilitySustainability strategySustainability Plan

During 2020, Recordati formalised the first Group Sustainability Plan, an essential tool that shares the future pathway with stakeholders. The Plan presents the ambitions of the Group and its commitments regarding sustainable and responsible development. 

The Group is driven by the belief that every day is an opportunity to improve on the day before and takes all the necessary steps to ensure sustainable, long-term economic growth. Growth and achievement of challenging business and sustainability goals are not incompatible: on the contrary, Recordati is convinced that responsible actions and generation of shared value contribute to the long-term success of the Company. 
Our Aspiration 

Improving people's health and quality of life is the basis of our mission, it is part of our DNA. Recordati's people have always given their utmost every day to pursue this goal. 

As emphasised by the World Health Organization (WHO), health is not merely the absence of disease or infirmity, but a state of complete physical, mental and social well-being. To improve health, it is therefore necessary to intervene on a number of determining factors, such as the social, physical and economic conditions under which people are born, live and work, including healthcare systems. In this context, in addition to institutions and governments, pharmaceutical companies must also develop strategies for the improvement of the healthcare system, in terms of availability, accessibility and quality of healthcare structures and the goods and services provided

We are living in a rapidly changing world that often raises concerns about sustainability for future generations. The current scenario in which we live has led us to reflect deeply on the relationship between humanity and nature and on the importance of an overall balance: well-being and health of people and the health of the planet are closely connected. We cannot be healthy in an unhealthy environment and with no health there is no wealth and no social equity.

With this systemic approach and in accordance with the 2030 Agenda for Sustainable Development priorities, we wish to contribute to supporting global development, promoting human well-being and protecting the environment. 

We want to continue to do our part. 

The Sustainability Plan focuses on 4 priority areas: 

    • Patient care
    • People care
    • Environmental protection
    • Responsible sourcing

These four strategic areas for sustainability are supported by a fifth fundamental pillar: ethics and integrity. These principles direct every aspect of the Group’s activities on a day-to-day basis.
The Sustainability Plan, defined in accordance with the materiality analysis, also highlights the contribution to achievement of 10 of the 17 Sustainable Development Goals (SDGs) of the Agenda 2030, the common goals signed by UN member states that outline a path of collaboration and responsibility to face the complex current challenges.

Process for definition of the Sustainability Plan

The sustainability goals were identified by the Environmental, Social & Governance department in close collaboration with the heads of other company departments. The Plan was shared with executive management, the Risk, Control and CSR Committee and the Board of Directors. 

Responsibility for achievement of the goals included in the Sustainability Plan is assigned to the representatives of the various departments involved, who have the resources, tools and expertise required for their implementation. To those involved in the implementation of the Plan, in the context of the Management by Objective (MBO) system, objectives of a social and environmental nature are assigned linked to the implementation of the Plan itself. 

Furthermore, the objectives of the MBO system for the Group General Manager include the definition, implementation, management and development of the strategic plan for sustainability integrated with Group business. 

For definition of the goals of the first Recordati group Sustainability Plan a gradual approach was preferred to support progressive implementation of projects aimed at continuous improvement. The Plan sets out periodic monitoring and updating. In fact, it will be updated on an annual basis in order to take account of the implementation status of existing projects and to set new goals.

Business ethics, integrity, anti-corruption

  • Distribute the Code of Ethics and train 100% of employees
  • Distribute anti-corruption policies and train 100% of employees. Specifically, distribution of and training on the new Group anti-bribery manual and country-specific anti-corruption laws (e.g. training on the 231 Model)
  • Begin third-party/partner due diligence based on anti-corruption policies through an ad hoc questionnaire

Privacy and data protection

  • Deliver a training programme on the GDPR (privacy) aimed at approximately 1,200 employees in foreign branches

Communication and transparency

  • Develop a new section on the Group's website dedicated to Sustainability

 Access to medicine and healthcare

  • Further enhance (by Recordati Rare Diseases inc.) the Patient Assistance Program (PAP) and Co-Pay Assistance Program (CAP) aimed at providing assistance to patients who are eligible to receive financial support for products
  • Continue to promote initiatives and training activities (including through the Recordati Rare Diseases Foundation) aimed at improving the diagnosis and treatment of rare diseases


  • Launch new projects to fight drug counterfeiting, focusing in particular on Brazil and other countries in relation to changing legislation
*Note: the table, relating to the Group's commitments to its patients, shows only some of the targets. Commitments regarding quality, product safety, research and development, etc. are intrinsically related to the business and are thus ongoing. More details on the Group's development plans are included in the Financial Statements.

 New work style, employee well-being and work-life balance

  • Define the project aimed at the full implementation of smart working for employees
  • Promote programmes aimed at encouraging healthy lifestyles through initiatives to promote sport, training on health, well-being and work-life balance (e.g. healthy eating, psychological well-being, parenthood and family), consultations with nutritionists, sports coaches, psychologists and smoking cessation therapists

Management and development of human resources

  • Promote training activities focused on management and leadership skills and the “new” skills required to manage new work style, especially those related to smart working (e.g. digital transformation, remote team management, work/life balance in the new online dimension)

Diversity and equal opportunities

  • Sign the Charter for Equal Opportunities and Equality at Work, which represents a declaration of commitment to adopt inclusive human resources policies, supported by the Italian Ministry of Labour and Social Policies

Health and Safety 

  • Reinforce a corporate culture aimed at preventing, monitoring and reducing occupational injuries through measures and initiatives to safeguard employee health and well-being (including installation of devices to facilitate and reduce the manual handling of loads, training and raising awareness)
Support for local communities 
  • Support medical and healthcare organisations dedicated to assisting those suffering from medical conditions and improving the quality of life of patients and their families through research and support projects and initiatives
  • Product donations to organisations that collect and distribute pharmaceuticals to healthcare facilities that regularly assist disadvantaged people who are unable to purchase medicines
  • Community support through solidarity, social and cultural initiatives aimed at promoting the growth and well-being of local communities

Fight against climate change 

  • 100% renewable electricity purchased for our European production and packaging sites and annexed offices. 
Note: The Recordati group has 8 production plants (2 chemical-pharmaceutical plants and 6 pharmaceutical production plants) in addition to one production plant dedicated to packaging.  Please note that 7 of the 9 production sites are in Europe and will be powered by renewable energy.
  • Install 2 inverter blowers at the Campoverde production plant to control the oxygenation levels of the wastewater treatment plant, enabling the regulation — and thereby improving the efficiency — of the machine's power based on the actual needs of the treatment plant (resulting in an estimated 50% reduction in electricity consumption compared to the current operating conditions of the unit scheduled for replacement)
  • Gradually replace traditional lighting systems with LED lights: 
    • complete replacement of the existing lighting systems with LED lights in the Utebo production plant and the intermediates warehouse of the Campoverde plant (Aprilia)
    • launch the project to replace the current lights with LED lights in the production department of the Milan plant (the replacement will be completed by 2023)
  • Install solar panels to generate electricity on the roof of the Utebo production plant and launch a feasibility study to assess the possibility of installing photovoltaic panels at the Cork production plant
  • Install specific energy consumption monitoring systems (steam and electricity use) at the production plant in Çerkezköy, Turkey and the Campoverde plant in order to obtain more accurate energy consumption data and to identify possible optimisation measures
  • Install a thermal solar system to produce hot water for the changing rooms at the Campoverde production site
  • Participate in the ForestaMI project, which aims to plant trees in the Milan Metropolitan Area in order to increase the amount of urban green spaces, improve citizen well-being and reduce atmospheric pollution
  • Progressive incentivisation and introduction of eco-friendly vehicles in the company’s fleet

Responsible waste management and circular economy initiatives 

  • Extend initiatives to recover and reuse chemical raw materials used in production processes, taking a circular economy approach, with a consequent positive impact on waste reduction and the use of natural resources
Note: The recovered raw materials may be reintroduced into internal production processes or through partnership agreements with third-party companies.
  • Feasibility study for a project to reduce certain types of hazardous waste through the installation of a system to capture certain heavy metals

Product sustainability (sustainable packaging initiatives)

  • Analyse possible packaging solutions with lower environmental impact

Promote a responsible supply chain

  • Distribute the new Code of Ethics to suppliers, starting with strategic suppliers
  • Roll out the Attitude Project group-wide, aimed at standardising the supplier selection and qualification process — including from an ethical and environmental standpoint — and creating a universal shared database to ensure supplier quality control
  • Define a strategic supplier management and monitoring plan that also considers ethical, social and environmental aspects